PTC Therapeutics (PTCT)
NASDAQ:PTCT
PTC Therapeutics (PTCT) Ownership Overview
1.50% Insiders
25.84% Mutual Funds
24.80% Other Institutional Investors
26.64% ETFs
21.22% Public Companies and
Individual Investors
The ownership structure of PTC Therapeutics (PTCT) stock is a mix of institutional, retail, and individual investors. Approximately 77.27% of the company’s stock is owned by Institutional Investors, 1.50% is owned by Insiders, and 21.22% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 13, 2026 | xxxxxxxxxxxxx | $170581 | |
Feb 20, 2026 | xxxxxxxxxxxxx | $511253 | |
Feb 20, 2026 | xxxxxxxxxxxxx | $172290 | |
Feb 20, 2026 | xxxxxxxxxxxxx | $216473 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $9495 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $1232754 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $1914192 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $6137112 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,476,637 | Institution | 11.45% | 634,934,679 | |
| 7,373,428 | Institution | 8.91% | 494,019,676 | |
| 6,223,316 | Institution | 7.52% | 416,962,172 | |
| 2,614,081 | Institution | 3.16% | 175,143,427 | |
| 2,250,428 | Institution | 2.72% | 150,778,676 | |
| 1,447,176 | Institution | 1.75% | 96,960,792 | |
| 1,136,188 | Institution | 1.37% | 76,124,596 | |
| 884,223 | Institution | 1.07% | 59,242,941 | |
| 854,330 | Institution | 1.03% | 57,240,110 | |
| 843,040 | Institution | 1.02% | 56,483,680 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,223,316 | Institution | 7.52% | 416,962,172 | |
| 2,250,428 | Institution | 2.72% | 150,778,676 | |
| 1,447,176 | Institution | 1.75% | 96,960,792 | |
| 884,223 | Institution | 1.07% | 59,242,941 | |
| 854,330 | Institution | 1.03% | 57,240,110 | |
| 843,040 | Institution | 1.02% | 56,483,680 | |
| 837,580 | Institution | 1.01% | 56,117,860 | |
| 537,434 | Institution | 0.65% | 36,008,078 | |
| 511,087 | Institution | 0.62% | 34,242,829 | |
| 460,430 | Institution | 0.56% | 30,848,810 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,870,531 | Institution | 5.88% | 326,325,577 | |
| 2,528,151 | Institution | 3.05% | 172,394,617 | |
| 1,944,855 | Institution | 2.35% | 130,305,285 | |
| 1,823,951 | Institution | 2.20% | 124,375,219 | |
| 1,293,553 | Institution | 1.56% | 87,250,150 | |
| 1,012,568 | Institution | 1.22% | 69,047,012 | |
| 874,795 | Institution | 1.06% | 59,652,271 | |
| 747,313 | Institution | 0.90% | 50,406,262 | |
| 683,892 | Institution | 0.83% | 45,820,764 | |
| 557,797 | Institution | 0.67% | 37,372,399 |
FAQ
Who Owns PTC Therapeutics (PTCT)?
According to the latest TipRanks data, approximately 24.80% of the company's stock is held by institutional investors, 1.50% is held by insiders, and 21.22% is held by retail investors.
What percentage of PTC Therapeutics (PTCT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 24.80% of PTC Therapeutics (PTCT) stock is held by institutional investors.
What percentage of PTC Therapeutics (PTCT) stock is held by retail investors?
According to the latest TipRanks data, approximately 21.22% of PTC Therapeutics (PTCT) stock is held by retail investors.
Who owns the most shares of PTC Therapeutics (PTCT)?
iShares owns the most shares of PTC Therapeutics (PTCT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.